Beam Therapeutics Inc. Dividend History (BEAM)
🤑 Beam Therapeutics Inc. has distributed a total of 41 dividends from 2004 to 2014
📉 During this 10 period their dividend has seen a -25.00% decrease in the payout amount
About Beam Therapeutics Inc.
Beam Therapeutics Inc. is a biotechnology company focused on developing precision genetic medicines through the use of base editing technology. The company was founded in 2017 by David R. Liu, Feng Zhang, and J. Keith Joung, who are pioneers in the field of gene editing and synthetic biology. Beam’s innovative approach allows for precise edits to single bases in the genome, offering potential treatments for a variety of genetic and other serious diseases. Headquartered in Cambridge, Massachusetts, Beam emphasizes groundbreaking research to push the boundaries of what is possible in genetic therapy. As of recent reports, Beam has been steadily growing and expanding its pipeline and collaborations, although specific financial data such as recent revenue figures might fluctuate and should be checked for the latest information. The company is publicly traded on the NASDAQ under the ticker symbol “BEAM.” Beam Therapeutics aspires to transform the lives of patients by advancing a new class of genetic medicines with the potential for lasting therapeutic impact.
CRISPR Therapeutics AG
Denali Therapeutics Inc.
Editas Medicine, Inc.
Intellia Therapeutics, Inc.
Twist Bioscience Corporation
Veracyte, Inc.
Verve Therapeutics, Inc.Beam Therapeutics, a biotechnology company developing precision genetic medicines, has appointed Sravan K. Emany as its new Chief Financial Officer. Emany brings extensive experience in the life sciences industry and will help guide Beam's growth and capital allocation strategy.
GlobeNewswire Inc. · Published on Fri Dec 06 2024
CRISPR Therapeutics' first gene therapy, Casgevy, has seen a slow launch, leading to a 47% drop in the stock price. However, the company has a strong pipeline and cash position, making it a risky but potentially rewarding investment.
The Motley Fool · Published on Sun Nov 24 2024Previous Payouts (41)
The most recent dividend Beam Therapeutics Inc. paid out was on March 3, 2014 (3933 days ago) for $0.225 per share
| Pay Date | Amount |
|---|---|
| March 3, 2014 | $0.225 |
| December 2, 2013 | $0.225 |
| September 3, 2013 | $0.23 |
| June 3, 2013 | $0.225 |
| March 1, 2013 | $0.225 |
| December 3, 2012 | $0.205 |
| September 4, 2012 | $0.205 |
| June 1, 2012 | $0.205 |
| March 1, 2012 | $0.205 |
| December 1, 2011 | $0.19 |
| September 1, 2011 | $0.19 |
| June 1, 2011 | $0.19 |
| March 1, 2011 | $0.19 |
| December 1, 2010 | $0.19 |
| September 1, 2010 | $0.19 |
| June 1, 2010 | $0.19 |
| March 1, 2010 | $0.19 |
| December 1, 2009 | $0.19 |
| September 1, 2009 | $0.19 |
| June 1, 2009 | $0.19 |
| March 2, 2009 | $0.44 |
| December 1, 2008 | $0.44 |
| September 2, 2008 | $0.44 |
| June 2, 2008 | $0.42 |
| March 3, 2008 | $0.42 |
| December 3, 2007 | $0.42 |
| September 4, 2007 | $0.42 |
| June 1, 2007 | $0.39 |
| March 1, 2007 | $0.39 |
| December 1, 2006 | $0.39 |
| September 1, 2006 | $0.39 |
| June 1, 2006 | $0.36 |
| March 1, 2006 | $0.36 |
| December 1, 2005 | $0.36 |
| September 1, 2005 | $0.36 |
| June 1, 2005 | $0.33 |
| March 1, 2005 | $0.33 |
| December 1, 2004 | $0.33 |
| September 1, 2004 | $0.33 |
| June 1, 2004 | $0.3 |
| March 1, 2004 | $0.3 |
Dividend data last updated Sun, 08 Dec 2024 07:27:23 GMT UTC